Accès ouvert
2026
article
OpenAlex
Halvor Ullern, Julie Aarmo Johannessen, Feyza Kasikci, Miriam Formica et autres
Birt-Hogg-Dubé syndrome (BHD) is an autosomal, dominant condition caused by Folliculin (FLCN) mutation and characterized by enhanced risk for kidney tumors. Previous studies have shown constitutive nuclear localization of the transcription factor TFEB and simultaneous hyperactivation of canonical MTORC1 signaling in the …
no
(code pays fourni par la source)
Accès ouvert
2026
dataset
OpenAlex
Halvor Ullern, Julie Aarmo Johannessen, Feyza Kasikci, Miriam Formica et autres
This repository contains data supporting the manuscript "FLCN loss is characterized by SQSTM1/p62 accumulation despite functional autophagy flux in Birt-Hogg-Dubé syndrome-associated kidney cancer"Ullern, Johannessen et al 2026 This dataset contains: bhd_data_deposit.Rdata : Complete tabular dataset with raw values used for graphs and …
no
(code pays fourni par la source)
Accès ouvert
2026
dataset
OpenAlex
Halvor Ullern, Julie Aarmo Johannessen, Feyza Kasikci, Miriam Formica et autres
This repository contains data supporting the manuscript "FLCN loss is characterized by SQSTM1/p62 accumulation despite functional autophagy flux in Birt-Hogg-Dubé syndrome-associated kidney cancer"Ullern, Johannessen et al 2026 This dataset contains: bhd_data_deposit.Rdata : Complete tabular dataset with raw values used for graphs and …
no
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Halvor Ullern, Julie Aarmo Johannessen, Feyza Kasikci, Miriam Formica et autres
Abstract Birt-Hogg-Dubé syndrome (BHD) is an autosomal, dominant condition caused by Folliculin (FLCN) mutation and characterized by enhanced risk for kidney tumors. Previous studies have shown constitutive nuclear localization of the transcription factor TFEB and simultaneous hyperactivation of canonical MTORC1 signaling in …
no
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Linda A.J. Hendricks, Katja C J Verbeek, Janneke H. M. Schuurs-Hoeijmakers, Robin De Putter et autres
BACKGROUND: PTEN hamartoma tumour syndrome (PHTS) patients have a high hereditary risk of cancer, especially breast (BC), endometrial (EC), and thyroid cancer (TC). However, the prognosis of PHTS-related cancers is unknown. METHODS: This European cohort study included adult PHTS patients with data …
nl, be, cy, cz, fr, de, it, lv, no, pt, si, es, se, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Linda A.J. Hendricks, Katja C J Verbeek, Janneke H. M. Schuurs-Hoeijmakers, Mirjam M. de Jong et autres
PURPOSE: Patients with PTEN Hamartoma Tumor Syndrome (PHTS) have high hereditary cancer risks for breast, endometrial, and thyroid cancer. Patients develop multiple primary cancers, but these risks remain uncertain. We aimed to provide the second primary cancer risk. METHODS: This European cohort …
nl, us, be, es, de, fr, gb, cz, si, pt, no, it, cy, lv, se
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Linda A.J. Hendricks, Katja C J Verbeek, Janneke H. M. Schuurs-Hoeijmakers, Arjen R. Mensenkamp et autres
Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data were collected via patient questionnaires (July 2020–March 2023) and genetic diagnoses from …
nl, us, be, cy, fr, de, it, lv, no, si, es, se
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Nina Strømsvik, Pernilla Turunen Olsson, Berit Gravdehaug, Hilde Lurås et autres
BACKGROUND: In South-Eastern Norway, genetic testing for BRCA1 and BRCA2 is offered to breast cancer patients by their treating surgeon or oncologist. Genetic counselling from a geneticist or a genetic counsellor is offered only to those who test positive for a pathogenic …
no
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Ingvil Berger, Siren Berland, Jezabel Rivero Rodriguez, Henrik Aamodt et autres
Lungemedisinsk avdeling Oslo universitetssykehus Hun har bidratt med idé, litteratursøk, tabell og foto, utarbeiding, revisjon og godkjenning av manus.Ingvil Berger er spesialist i lungemedisin og overlege.Forfatteren har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter. SIREN BERLANDAvdeling for medisinsk genetikk Haukeland universitetssjukehus Hun …
no
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Eli Marie Grindedal, Kjersti Jørgensen, Pernilla Turunen Olsson, Berit Gravdehaug et autres
Studies have shown that a significant number of eligible breast cancer patients are not offered genetic testing or referral to genetic counseling. To increase access to genetic testing in South Eastern Norway, testing has since 2014 been offered directly to breast cancer …
no
(code pays fourni par la source)
Accès ouvert
2019
preprint
OpenAlex
Eli Marie Grindedal, Kjersti Jørgensen, Pernilla Turunen Olsson, Berit Gravdehaug et autres
Abstract Background: Identification of a BRCA mutation in a breast cancer patient provides critical information both for treatment decisions and for prevention of new cancers. In South Eastern Norway, genetic testing of the BRCA genes has been mainstreamed into breast cancer care. …
no
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Eva Sigstad, Krystyna Kotanska Grøholt, Kjersti Jørgensen, Astrid Tenden Stormorken et autres